Description |
dystrobrevin beta |
abl interactor 2 |
Image |
No pdb structure |
|
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy) ( 28112199)
- Body mass index ( 26426971)
- Body mass index (age <50) ( 26426971)
- Body mass index (age>50) ( 26426971)
- Body mass index x sex x age interaction (4df test) ( 26426971)
- Body shape index ( 34021172)
- Cutaneous malignant melanoma ( 32341527)
- Decreased low contrast letter acuity in multiple sclerosis ( 31289819)
- Height ( 18391951)
- Heschl's gyrus morphology ( 25130324)
- High light scatter reticulocyte count ( 32888494)
- High light scatter reticulocyte percentage of red cells ( 32888494)
- Intracranial aneurysm ( 29531279)
- LDL cholesterol ( 21347282)
- Macular thickness ( 30535121)
- Multiple myeloma ( 22120009 26007630)
- Multiple myeloma and monoclonal gammopathy ( 26007630)
- Nevus count or cutaneous melanoma ( 32341527)
- Resistant hypertension ( 31545351)
- Response to platinum-based chemotherapy (cisplatin) ( 21844884)
- Reticulocyte count ( 32888494)
- Reticulocyte fraction of red cells ( 32888494)
- Triglyceride levels ( 32203549)
- Type 2 diabetes ( 30297969)
- Waist circumference adjusted for body mass index ( 28552196 34021172)
- Waist-hip index ( 34021172)
- Waist-to-hip ratio adjusted for BMI ( 34021172)
- Working memory ( 31598132)
|
- Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL) ( 28090653)
- Brain morphology (min-P) ( 32665545)
- Brain morphology (MOSTest) ( 32665545)
- Butyrylcholinesterase levels ( 21862451)
- Cortical surface area (MOSTest) ( 32665545)
- Cortical thickness (MOSTest) ( 32665545)
- Diverticular disease ( 30177863)
- Subclinical atherosclerosis traits (other) ( 17903303)
- Subcortical volume (min-P) ( 32665545)
- Subcortical volume (MOSTest) ( 32665545)
- Trunk fat mass ( 28552196)
- Urinary albumin-to-creatinine ratio ( 31511532)
|
Interacting Genes |
62 interacting genes:
ABI1
ABI2
ABI3
AMOTL2
BEGAIN
CBY2
CCDC136
CCDC196
CCDC85B
CCDC88B
CCHCR1
CEP55
CEP63
COG6
CTBP2
DEUP1
DMD
DTNBP1
FAM167A
FSD2
GGA1
HMG20A
INSYN1
KIF5A
KIF5B
KRT15
KRT27
KRT31
KRT33B
KRT35
KRT38
KRT40
LURAP1
MB21D2
MTUS2
NDEL1
NUP62
PICK1
POU6F2
PPFIA1
PPFIBP2
PPP1R13B
PRKAR1B
PRTFDC1
SNTA1
SNTG1
SNTG2
SPZ1
SSBP3
TFIP11
TRAF2
TRIM27
TRIM37
TRIM54
TSACC
TXLNA
USHBP1
UTRN
VCP
VPS52
ZBTB9
ZRANB1
|
202 interacting genes:
ABI1
ABI3
ABL1
ABL2
ABLIM3
ADAM19
AKAP8L
AKAP9
ANKRD55
ANKS1A
ARHGAP32
ARMC7
ATP23
BAG4
BIN3
BLOC1S5
BLOC1S6
BORCS6
C19orf54
C1orf109
C1orf216
C20orf202
C4orf17
CCDC102B
CCDC115
CCDC57
CCDC74B
CCHCR1
CDK6
CENPH
CENPQ
CEP44
CEP57
CLPP
COG3
CRX
CUEDC1
DCTN2
DISC1
DLGAP2
DLGAP4
DNAI7
DTNB
EFS
EGLN3
EGR4
EIF3H
ENAH
ENKD1
EPS8L1
FAM161B
FAM166B
FAM214B
FAM90A1
FAM9C
FBXL19
FHL5
FKBP1A
FOXD4L1
GAS2L2
GCC1
GFAP
GGN
GPANK1
HGS
HHEX
HNRNPK
HOMER3
HSF2BP
ICOS
IFT20
IHO1
INCA1
INO80B
INSYN1
KHDRBS1
KIAA1217
KIFC3
KNSTRN
KRT13
KRT14
KRT15
KRT19
KRT20
KRT24
KRT27
KRT31
KRT33B
KRT34
KRT36
KRT75
LENG1
LGALS9B
LHX3
LHX8
LMO1
LMO2
LMO3
LMO4
LNX1
LURAP1
LZTS2
MAGEA1
MCM7
MED10
MED11
MED29
MEOX2
MRFAP1
MRFAP1L1
MRPL28
MRPL44
MYO15B
MYOG
MYOZ3
NCK1
NCK2
NCKIPSD
NFASC
NHSL2
NIF3L1
NME4
NUP62
OGT
OIP5
OOEP
PAK2
PCM1
PDLIM7
PFDN5
PHETA1
PHF1
PIN1
PLEKHN1
POMC
PPIF
PPP3CA
PRAM1
PRDM14
PRDM6
PRKAA1
PRKAA2
PRR16
PRR20A
PRR20B
PRR20C
PRR20D
PRR20E
PSMA1
PWWP2B
RABEP1
RABGEF1
RASD1
RNPS1
RPP25
RSPH14
RUSC1
SATB2
SCGN
SDCBP
SH3BP1
SH3KBP1
SHANK3
SLA
SMARCB1
SMARCD1
SNAP23
SNAP91
SNAPIN
SNX18
SNX7
SORBS3
STAM2
STX19
STX4
TFIP11
TLE5
TPM2
TRAF3IP1
TRIM32
TRIM72
TRIML2
TRIP6
UBQLN2
USHBP1
USP2
VARS2
VASP
VCL
VPS28
VPS37C
WASF2
WASF3
WASHC1
WASHC3
WASL
WIPF1
WWOX
ZFP90
ZMYND12
ZNF474
ZNF688
|
Entrez ID |
1838 |
10152 |
HPRD ID |
09091 |
07338 |
Ensembl ID |
ENSG00000138101
|
ENSG00000138443
|
Uniprot IDs |
B7Z202
B7Z6A9
E7EVB6
E9PEY4
O60941
Q1I0L3
|
A0A0C4DG21
A0A7D9NKC8
B7Z836
F8WAL6
Q9NYB9
|
PDB IDs |
|
2ED0
3P8C
4N78
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|